KRAS and malignant colon neoplasm: Aiming to develop an approach to evaluate the benefits of a combination of c-Met targeting and irradiation or chemical agents on malignant colon cancer cells with KRAS mutations, we generated a stable cell line in which the expression of c-Met (both an essential gene for host growth and also an oncogene) was conditionally regulated.